chr11-1235227-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002458.3(MUC5B):c.2769+4C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00361 in 1,612,418 control chromosomes in the GnomAD database, including 189 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002458.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MUC5B | NM_002458.3 | c.2769+4C>T | splice_region_variant, intron_variant | ENST00000529681.5 | NP_002449.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUC5B | ENST00000529681.5 | c.2769+4C>T | splice_region_variant, intron_variant | 5 | NM_002458.3 | ENSP00000436812.1 | ||||
MUC5B | ENST00000525715.5 | n.2827+4C>T | splice_region_variant, intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0197 AC: 3003AN: 152104Hom.: 101 Cov.: 33
GnomAD3 exomes AF: 0.00502 AC: 1244AN: 248034Hom.: 43 AF XY: 0.00390 AC XY: 525AN XY: 134726
GnomAD4 exome AF: 0.00191 AC: 2796AN: 1460196Hom.: 87 Cov.: 32 AF XY: 0.00164 AC XY: 1191AN XY: 726372
GnomAD4 genome AF: 0.0198 AC: 3017AN: 152222Hom.: 102 Cov.: 33 AF XY: 0.0193 AC XY: 1435AN XY: 74428
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | 2769+4C>T in intron 22 of MUC5B: This variant is not expected to have clinical s ignificance because it has been identified in 6.2% (261/4206) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs56252247). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at